These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 27546350)
21. Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance. Cordts E; Steckel H Eur J Pharm Biopharm; 2012 Oct; 82(2):417-23. PubMed ID: 22902789 [TBL] [Abstract][Full Text] [Related]
22. Lactose characteristics and the generation of the aerosol. Pilcer G; Wauthoz N; Amighi K Adv Drug Deliv Rev; 2012 Mar; 64(3):233-56. PubMed ID: 21616107 [TBL] [Abstract][Full Text] [Related]
23. The effect of mixing on the dispersibility of adhesive mixtures for inhalation. Comparison of high shear and Turbula mixers. Thalberg K; Ivarsson L; Svensson M; Elfman P; Ohlsson A; Stuckel J; Lyberg AM Eur J Pharm Sci; 2024 Feb; 193():106679. PubMed ID: 38128841 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance. Jones MD; Buckton G Int J Pharm; 2016 Jul; 509(1-2):419-430. PubMed ID: 27265314 [TBL] [Abstract][Full Text] [Related]
25. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler. de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246 [TBL] [Abstract][Full Text] [Related]
26. A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect? de Boer AH; Chan HK; Price R Adv Drug Deliv Rev; 2012 Mar; 64(3):257-74. PubMed ID: 21565232 [TBL] [Abstract][Full Text] [Related]
27. The relationship between drug concentration, mixing time, blending order and ternary dry powder inhalation performance. Jones MD; Santo JG; Yakub B; Dennison M; Master H; Buckton G Int J Pharm; 2010 May; 391(1-2):137-47. PubMed ID: 20211715 [TBL] [Abstract][Full Text] [Related]
28. Mixing of dry powders for inhalation: A review. Spahn JE; Zhang F; Smyth HDC Int J Pharm; 2022 May; 619():121736. PubMed ID: 35405281 [TBL] [Abstract][Full Text] [Related]
34. Alternative carriers in dry powder inhaler formulations. Rahimpour Y; Kouhsoltani M; Hamishehkar H Drug Discov Today; 2014 May; 19(5):618-26. PubMed ID: 24269834 [TBL] [Abstract][Full Text] [Related]
35. Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler. Li J; Ma S; He X; Sun Y; Zhang X; Guan J; Mao S Int J Pharm; 2023 Jul; 642():123179. PubMed ID: 37364785 [TBL] [Abstract][Full Text] [Related]
36. Optical diagnostics studies of air flow and powder fluidisation in Nexthaler®. Part II: Use of fluorescent imaging to characterise transient release of fines from a dry powder inhaler. Merusi C; Brambilla G; Long EJ; Hargrave GK; Versteeg HK Int J Pharm; 2018 Oct; 549(1-2):96-108. PubMed ID: 30017819 [TBL] [Abstract][Full Text] [Related]
37. Elucidation of the effect of added fines on the performance of dry powder inhalation formulations. Stankovic-Brandl M; Radivojev S; Sailer P; Penz FK; Paudel A Int J Pharm; 2022 Dec; 629():122359. PubMed ID: 36332830 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers. Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343 [TBL] [Abstract][Full Text] [Related]
39. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance. Faulhammer E; Wahl V; Zellnitz S; Khinast JG; Paudel A Int J Pharm; 2015 Aug; 491(1-2):231-42. PubMed ID: 26136200 [TBL] [Abstract][Full Text] [Related]
40. The role of the solid state and physical properties of the carrier in adhesive mixtures for lung delivery. Della Bella A; Salomi E; Buttini F; Bettini R Expert Opin Drug Deliv; 2018 Jul; 15(7):665-674. PubMed ID: 28829232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]